Metropolis Healthcare P/E Ratio

METROPOLIS • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
53.64
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 53.64
Current Price ₹434.00
EPS (TTM) ₹28.29
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 60.25
Historical Range 32.92 - 118.44
Percentile 42.9%

Sector Context

Sector Average 57.91
Sector Median 37.87
Sector Rank #11 of 47
Sector Percentile 23.4%

Earnings Breakdown (TTM)

TTM EPS ₹32.55
Sept 2025 ₹10.17
Mar 2025 ₹5.69

Key P/E Ratio Insights for Metropolis Healthcare

  • Stock appears overvalued with PE of 53.64, suggesting caution for new investments

P/E Ratio Historical Trend for Metropolis Healthcare

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 63.18 32.55 ₹2056.50 NSE High
2024 56.34 29.72 ₹1674.55 NSE High
2023 54.11 24.35 ₹1317.65 NSE High
2022 118.44 29.21 ₹3459.65 NSE High
2021 43.7 46.11 ₹2015.00 NSE High
2020 53.06 27.04 ₹1434.65 NSE High
2019 32.92 29.16 ₹959.85 NSE High

Sector P/E Ratio Comparison

Comparing Metropolis Healthcare with other companies in Healthcare Services sector
Sector Average
57.91
Sector Median
37.87
Lowest P/E
6.2
Highest P/E
375.68
Companies
47
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Star Imaging And Path Lab STARIMAGIN 6.2 ₹89 Low
Deccan Health Care DECCAN 8.98 ₹18 Low
Nidan Labs & Healthcare NIDAN 10.21 ₹19 Low
Shanmuga Hospital SHANMUGA 11.83 ₹47 Low
One Global Service Provi… ONEGLOBAL 16.94 ₹1,055 Moderate
Abate AS Industries ABATEAS 17.6 ₹182 Moderate
3B BlackBio DX 3BBLACKBIO 18.41 ₹1,046 Moderate
Tejnaksh Healthcare TEJNAKSH 19.16 ₹23 Moderate
Asarfi Hospital ASARFI 19.77 ₹348 Moderate
Clinitech Laboratory CTLLAB 20.23 ₹8 Moderate